These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 7911429)

  • 21. Inhibition of dihydropteridine reductase from human liver and rat striatal synaptosomes by apomorphine and its analogs.
    Shen RS; Smith RV; Davis PJ; Abell CW
    J Biol Chem; 1984 Jul; 259(14):8994-9000. PubMed ID: 6746636
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis and dopamine receptor binding of sulfur-containing aporphines.
    Tóth M; Berényi S; Csutorás C; Kula NS; Zhang K; Baldessarini RJ; Neumeyer JL
    Bioorg Med Chem; 2006 Mar; 14(6):1918-23. PubMed ID: 16290940
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preparation and pharmacological evaluation of enantiomers of certain nonoxygenated aporphines: (+)- and (-)-aporphine and (+)- and (-)-10-methylaporphine.
    Cannon JG; Raghupathi R; Moe ST; Johnson AK; Long JP
    J Med Chem; 1993 May; 36(10):1316-8. PubMed ID: 8098770
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The interaction of RS 25259-197, a potent and selective antagonist, with 5-HT3 receptors, in vitro.
    Wong EH; Clark R; Leung E; Loury D; Bonhaus DW; Jakeman L; Parnes H; Whiting RL; Eglen RM
    Br J Pharmacol; 1995 Feb; 114(4):851-9. PubMed ID: 7773546
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differences in dopamine receptor reserve for N-n-propylnorapomorphine enantiomers: single unit recording studies after partial inactivation of receptors by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline.
    Cox RF; Waszczak BL
    Mol Pharmacol; 1989 Jan; 35(1):125-31. PubMed ID: 2563304
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vascular effects of apomorphine and related compounds in the perfused rat kidney.
    Schmidt M; Imbs JL; Neumeyer JL; Giesen EM; Schwartz J
    Eur J Pharmacol; 1984 Jan; 97(1-2):75-85. PubMed ID: 6141949
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dopamine D(2) activity of R-(-)-apomorphine and selected analogs: a microdialysis study.
    Rodenhuis N; Dijkstra D; de Boer P; Vermeulen ES; Timmerman W; Wikström HV
    Eur J Pharmacol; 2000 Jan; 387(1):39-45. PubMed ID: 10633158
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tissue levels of N-n-propylnorapomorphine after treatment with (-)10,11-methylenedioxy-N-n-propylnoraporphine, an orally long-acting prodrug active at central dopamine receptors.
    Sperk G; Campbell A; Baldessarini RJ; Stoll A; Neumeyer JL
    Neuropharmacology; 1982 Dec; 21(12):1311-6. PubMed ID: 6891445
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structure-affinity relationships of halogenated predicentrine and glaucine derivatives at D1 and D2 dopaminergic receptors: halogenation and D1 receptor selectivity.
    Asencio M; Hurtado-Guzmán C; López JJ; Cassels BK; Protais P; Chagraoui A
    Bioorg Med Chem; 2005 Jun; 13(11):3699-704. PubMed ID: 15862999
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential serotoninergic and dopaminergic activities of the (R)- and the (S)-enantiomers of 2-(di-n-propylamino)tetralin.
    Yu H; Liu Y; Malmberg A; Mohell N; Hacksell U; Lewander T
    Eur J Pharmacol; 1996 May; 303(3):151-62. PubMed ID: 8813561
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aporphines 65: chemical, microbial synthesis and characterization by gas chromatography/mass spectrometry of (R)-(-)-10-hydroxy 11-methoxy-N-n-propylnoraporphine, a potential metabolite of N-n-propylnorapomorphine.
    Neumeyer JL; Abdel-Maksoud HM; Trainor TM; Vouros P; Davis PJ
    Biomed Environ Mass Spectrom; 1986 May; 13(5):223-9. PubMed ID: 2941089
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quantitative PET analysis of the dopamine D2 receptor agonist radioligand 11C-(R)-2-CH3O-N-n-propylnorapomorphine in the human brain.
    Otsuka T; Ito H; Halldin C; Takahashi H; Takano H; Arakawa R; Okumura M; Kodaka F; Miyoshi M; Sekine M; Seki C; Nakao R; Suzuki K; Finnema S; Hirayasu Y; Suhara T; Farde L
    J Nucl Med; 2009 May; 50(5):703-10. PubMed ID: 19372485
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dopamine D1 receptors are involved in the modulation of D2 receptors induced by cholecystokinin receptor subtypes in rat neostriatal membranes.
    Li XM; Hedlund PB; Agnati LF; Fuxe K
    Brain Res; 1994 Jul; 650(2):289-98. PubMed ID: 7953694
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prolonged D2 antidopaminergic activity of alkylating and nonalkylating derivatives of spiperone in rat brain.
    Baldessarini RJ; Kula NS; Campbell A; Bakthavachalam V; Yuan J; Neumeyer JL
    Mol Pharmacol; 1992 Nov; 42(5):856-63. PubMed ID: 1435753
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neurotensin in vitro markedly reduces the affinity in subcortical limbic 3H-N-propylnorapomorphine binding sites.
    Agnati LF; Fuxe K; Benfenati F; Battistini N
    Acta Physiol Scand; 1983 Dec; 119(4):459-61. PubMed ID: 6320589
    [No Abstract]   [Full Text] [Related]  

  • 36. 5-HT1A-receptor antagonism: N-alkyl derivatives of (R)-(-)-8,11-dimethoxynoraporphine.
    Cannon JG; Jackson H; Long JP; Leonard P; Bhatnagar RK
    J Med Chem; 1989 Aug; 32(8):1959-62. PubMed ID: 2569041
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Caffeine cross-tolerance to selective dopamine D1 and D2 receptor agonists but not to their synergistic interaction.
    Garrett BE; Holtzman SG
    Eur J Pharmacol; 1994 Sep; 262(1-2):65-75. PubMed ID: 7813580
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Affinity profile at alpha(1)- and alpha(2)-adrenoceptor subtypes and in vitro cardiovascular actions of (+)-boldine.
    Eltze M; Grebe T; Michel MC; Czyborra P; Ullrich B
    Eur J Pharmacol; 2002 May; 443(1-3):151-68. PubMed ID: 12044805
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Convenient synthesis of 18F-radiolabeled R-(-)-N-n-propyl-2-(3-fluoropropanoxy-11-hydroxynoraporphine.
    Sromek AW; Zhang S; Akurathi V; Packard AB; Li W; Alagille D; Morley TJ; Baldwin R; Tamagnan G; Neumeyer JL
    J Labelled Comp Radiopharm; 2014 Dec; 57(14):725-9. PubMed ID: 25400260
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The binding of [3H]N-(chloroethyl)-norapomorphine to rat striatal membranes.
    Kilpatrick GJ; Jenner P; Marsden CD
    Eur J Pharmacol; 1984 Dec; 107(1):71-8. PubMed ID: 6084599
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.